551 related articles for article (PubMed ID: 18778892)
1. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
Su J; Chen X; Kanekura T
Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
[TBL] [Abstract][Full Text] [Related]
2. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
[TBL] [Abstract][Full Text] [Related]
3. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
4. CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase.
Nishibaba R; Higashi Y; Su J; Furukawa T; Kawai K; Kanekura T
J Dermatol; 2012 Jan; 39(1):63-7. PubMed ID: 21967109
[TBL] [Abstract][Full Text] [Related]
5. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.
Chen X; Lin J; Kanekura T; Su J; Lin W; Xie H; Wu Y; Li J; Chen M; Chang J
Cancer Res; 2006 Dec; 66(23):11323-30. PubMed ID: 17145878
[TBL] [Abstract][Full Text] [Related]
6. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
Izumi H; Takahashi M; Uramoto H; Nakayama Y; Oyama T; Wang KY; Sasaguri Y; Nishizawa S; Kohno K
Cancer Sci; 2011 May; 102(5):1007-13. PubMed ID: 21306479
[TBL] [Abstract][Full Text] [Related]
7. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.
Baba M; Inoue M; Itoh K; Nishizawa Y
Biochem Biophys Res Commun; 2008 Sep; 374(1):111-6. PubMed ID: 18616931
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
[TBL] [Abstract][Full Text] [Related]
9. CD147/basigin promotes progression of malignant melanoma and other cancers.
Kanekura T; Chen X
J Dermatol Sci; 2010 Mar; 57(3):149-54. PubMed ID: 20060267
[TBL] [Abstract][Full Text] [Related]
10. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of MCT1, CD147, and LDH in mitochondrial inner membrane of L6 muscle cells: evidence of a mitochondrial lactate oxidation complex.
Hashimoto T; Hussien R; Brooks GA
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1237-44. PubMed ID: 16434551
[TBL] [Abstract][Full Text] [Related]
12. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
[TBL] [Abstract][Full Text] [Related]
13. Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction.
Marchiq I; Albrengues J; Granja S; Gaggioli C; Pouysségur J; Simon MP
Oncotarget; 2015 Sep; 6(28):24636-48. PubMed ID: 26284589
[TBL] [Abstract][Full Text] [Related]
14. Basigin interacts with both MCT1 and MCT2 in murine spermatozoa.
Mannowetz N; Wandernoth P; Wennemuth G
J Cell Physiol; 2012 May; 227(5):2154-62. PubMed ID: 21792931
[TBL] [Abstract][Full Text] [Related]
15. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo.
Li R; Pan Y; He B; Xu Y; Gao T; Song G; Sun H; Deng Q; Wang S
Int J Oncol; 2013 Dec; 43(6):1885-94. PubMed ID: 24064772
[TBL] [Abstract][Full Text] [Related]
17. CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.
Walters DK; Arendt BK; Jelinek DF
Cell Cycle; 2013 Oct; 12(19):3175-83. PubMed ID: 24013424
[TBL] [Abstract][Full Text] [Related]
18. Basal and stimulated lactate fluxes in primary cultures of astrocytes are differentially controlled by distinct proteins.
Maekawa F; Minehira K; Kadomatsu K; Pellerin L
J Neurochem; 2008 Nov; 107(3):789-98. PubMed ID: 18761711
[TBL] [Abstract][Full Text] [Related]
19. Functional activity of a monocarboxylate transporter, MCT1, in the human retinal pigmented epithelium cell line, ARPE-19.
Majumdar S; Gunda S; Pal D; Mitra AK
Mol Pharm; 2005; 2(2):109-17. PubMed ID: 15804185
[TBL] [Abstract][Full Text] [Related]
20. Glucose affects monocarboxylate cotransporter (MCT) 1 expression during mouse preimplantation development.
Jansen S; Esmaeilpour T; Pantaleon M; Kaye PL
Reproduction; 2006 Mar; 131(3):469-79. PubMed ID: 16514190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
